TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement June 26, 1987
TCL Archive NCI Expected of Fund Cancer Education Grants In Fiscal 1986; Final Fate to Be Decided This Week March 7, 1986